Literature DB >> 15616817

Long-term outcome after internal sphincter myectomy for internal sphincter achalasia.

M Heikkinen1, H Lindahl, R J Rintala.   

Abstract

Anal internal sphincter achalasia is a rare cause of refractory constipation. It is usually treated by internal sphincter myectomy (ISM). The aim of this study was to evaluate the long-term outcome of patients who had undergone ISM for internal sphincter achalasia. Bowel habits, fecal continence, and quality of life were evaluated using a questionnaire. Fecal continence was quantitatively assessed by a score described by Holschneider. A questionnaire was sent to 13 patients (11 male, two female) operated on by ISM for intractable constipation caused by internal sphincter achalasia between 1983 and 1993. Ten patients responded and were included in the study. At the time of the study, three of the 10 patients required oral medication for constipation and had one to three bowel movements per week. One of the 10 patients had three to five bowel movements per day, and the others had one to two bowel movements per day. Four patients had normal and six patients had good continence scores. Four of the patients reported mild social problems, and one had problems associated with sports. Refractory constipation in the majority of patients with internal sphincter achalasia can be treated by ISM. However, in the long term, a significant number of patients suffer from soiling-related social problems.

Entities:  

Mesh:

Year:  2004        PMID: 15616817     DOI: 10.1007/s00383-004-1332-2

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  9 in total

1.  Rectal myectomy in Hirschsprung disease: a decade of experience.

Authors:  H B Lynn; J A van Heerden
Journal:  Arch Surg       Date:  1975-08

2.  Studies of distal colonic motility in children. IV. Achalasia of the distal rectal segment despite presence of ganglia in the myenteric plexuses of this area.

Authors:  M DAVIDSON; C H BAUER
Journal:  Pediatrics       Date:  1958-05       Impact factor: 7.124

3.  Long-term anal sphincter performance after surgery for Hirschsprung's disease.

Authors:  M Heikkinen; R Rintala; P Luukkonen
Journal:  J Pediatr Surg       Date:  1997-10       Impact factor: 2.545

4.  Internal anal sphincter achalasia: outcome after internal sphincter myectomy.

Authors:  D De Caluwé; A Yoneda; U Akl; P Puri
Journal:  J Pediatr Surg       Date:  2001-05       Impact factor: 2.545

Review 5.  Variant Hirschsprung's disease.

Authors:  P Puri
Journal:  J Pediatr Surg       Date:  1997-02       Impact factor: 2.545

6.  Ganglion cell distribution in the normal rectum and anal canal. A basis for the diagnosis of Hirschsprung's disease by anorectal biopsy.

Authors:  R T Aldridge; P E Campbell
Journal:  J Pediatr Surg       Date:  1968-08       Impact factor: 2.545

7.  Rectal myectomy for aganglionic megacolon.

Authors:  H B Lynn
Journal:  Mayo Clin Proc       Date:  1966-05       Impact factor: 7.616

8.  Ultrashort Hirschsprung's disease: myth or reality.

Authors:  I R Neilson; S Yazbeck
Journal:  J Pediatr Surg       Date:  1990-11       Impact factor: 2.545

9.  Absence of NADPH-diaphorase activity in internal anal sphincter (IAS) achalasia.

Authors:  H Hirakawa; H Kobayashi; D S O'Briain; P Puri
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-01       Impact factor: 2.839

  9 in total
  11 in total

1.  A comparison of clinical protocols for assessing postoperative fecal continence in anorectal malformation.

Authors:  Takanori Ochi; Tadaharu Okazaki; Go Miyano; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

Review 2.  Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention.

Authors:  Farokh R Demehri; Ihab F Halaweish; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

Review 3.  Classification and diagnostic criteria of variants of Hirschsprung's disease.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

4.  Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.

Authors:  A I Koivusalo; M P Pakarinen; R J Rintala
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

5.  Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction.

Authors:  Katy Irani; Leonel Rodriguez; Daniel P Doody; Allan M Goldstein
Journal:  Pediatr Surg Int       Date:  2008-04-29       Impact factor: 1.827

6.  Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2012-08       Impact factor: 1.827

7.  Gastrointestinal motility disorders in children.

Authors:  Lusine Ambartsumyan; Leonel Rodriguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

8.  Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.

Authors:  Tomas Wester; Anna Löf Granström
Journal:  Pediatr Surg Int       Date:  2015-01-24       Impact factor: 1.827

Review 9.  Hirschsprung-associated enterocolitis: prevention and therapy.

Authors:  Philip K Frykman; Scott S Short
Journal:  Semin Pediatr Surg       Date:  2012-11       Impact factor: 2.754

10.  Long-term outcome of internal sphincter myectomy in patients with internal anal sphincter achalasia.

Authors:  Reshma Doodnath; Prem Puri
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.